Trials show promise for intravitreal faricimab in retinal disease
Feb 02, 2022
Faricimab noninferior to aflibercept for visual acuity gains in neovascular age-related macular degeneration, diabetic macular edema
FDA approves ‘breakthrough’ therapy for diabetic eye disorder
By
John Hall
Mar 26, 2015
The FDA announced Wednesday that it has granted “breakthrough therapy designation” to the drug Eylea, and expanded its approved use for the treatment of diabetic retinopathy in patients with...